Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.66 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.46 |
| ▸ | BHMT | Q93088 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18832145 | 1.00 | GPR84 (0.66) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL18832138 | 1.00 | GPR84 (0.66) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL18832143 | 0.98 | GPR84 (0.62) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL11550378 | 0.93 | GPR84 (0.78) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL4951710 | 0.92 | GPR84 (0.59) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL723123 | 0.84 | GPR84 (0.52) | GPR84FFAR1BHMT | |
| SCHEMBL722785 | 0.83 | GPR84 (0.62) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL9937927 | 0.81 | GPR84 (0.59) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL7377715 | 0.81 | GPR84 (0.53) | GPR84FFAR1MAPTGMNNTP53 | |
| SCHEMBL18832137 | 0.80 | BHMT (0.70) | MAPTGMNNTP53POLBTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106795511-B | Oxidase, polynucleotide encoding the same, and use thereof | 住友化学株式会社 | 2020-02-11 | — | — | CN | disclosed |
| CN-106661571-B | Oxidase, polynucleotide encoding the same, and use thereof | 住友化学株式会社 | 2019-12-20 | — | — | CN | disclosed |
| EP-3168301-B1 | OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE OF THESE | SUMITOMO CHEMICAL CO (JP) | 2019-11-20 | — | — | EP | disclosed |
| US-10364448-B2 | Method for producing L-α-amino acid compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-30 | — | — | US | disclosed |
| US-10351829-B2 | Oxidase, polynucleotide that codes for same, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-16 | — | — | US | disclosed |
| US-20170191097-A1 | OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-06 | — | — | US | disclosed |
| US-20170159029-A1 | OXIDASE, POLYNUCLEOTIDE THAT CODES FOR SAME, AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-08 | — | — | US | disclosed |
| EP-3168301-A1 | OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE OF THESE | Sumitomo Chemical Company, Limited (JP) | 2017-05-17 | — | — | EP | disclosed |
| EP-3168302-A1 | OXIDASE, POLYNUCLEOTIDE THAT CODES FOR SAME, AND USES FOR BOTH | Sumitomo Chemical Company, Limited (JP) | 2017-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351829-B2 | Oxidase, polynucleotide that codes for same, and use thereof | DAO, PNPO, HAO1 | GPR84 4093/4885FFAR1 2509/4885MAPT 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.